Article metrics

Download PDFPDF

Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study

 

Online download statistics by month:

Online download statistics by month: March 2019 to August 2021

AbstractFullPdf
Mar 2019550561129
Apr 2019762794123
May 2019703698144
Jun 201931331288
Jul 201919919248
Aug 201921420851
Sep 201915314744
Oct 201920219638
Nov 201916515938
Dec 201913512542
Jan 202018116639
Feb 202017917763
Mar 202016816250
Apr 202013312833
May 2020136134103
Jun 202013012652
Jul 2020979460
Aug 202011611535
Sep 202014413438
Oct 202013012536
Nov 202012011322
Dec 2020847929
Jan 202114913737
Feb 202111910826
Mar 202114514244
Apr 202112411729
May 202161861644
Jun 202113713336
Jul 20211019521
Aug 202111811040
Total652564031582